173 related articles for article (PubMed ID: 6193358)
1. Profile of coronary vasodilator and cardiac actions of bepridil revealed by use of isolated, blood-perfused heart preparations of the dog.
Kawada M; Satoh K; Taira N
J Cardiovasc Pharmacol; 1983; 5(4):604-12. PubMed ID: 6193358
[TBL] [Abstract][Full Text] [Related]
2. Selectivity of alinidine, a bradycardic agent, for SA nodal automaticity versus other cardiac activities in isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):88-102. PubMed ID: 6517649
[TBL] [Abstract][Full Text] [Related]
3. Analyses of the cardiac action of the bradycardic agent, AQ-A 39, by use of isolated, blood-perfused dog-heart preparations.
Kawada M; Satoh K; Taira N
J Pharmacol Exp Ther; 1984 Feb; 228(2):484-90. PubMed ID: 6694121
[TBL] [Abstract][Full Text] [Related]
4. Are the cardiovascular effects of gentamicin similar to those of calcium antagonists?
Gotanda K; Yanagisawa T; Satoh K; Taira N
Jpn J Pharmacol; 1988 Jul; 47(3):217-27. PubMed ID: 3221528
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular profile of AN-132, a new diamine derivative antiarrhythmic agent, revealed in the isolated, blood-perfused dog heart.
Gotanda K; Satoh K; Taira N
Tohoku J Exp Med; 1988 Sep; 156(1):65-78. PubMed ID: 3194907
[TBL] [Abstract][Full Text] [Related]
6. Cardiac versus coronary vasodilator actions of KB-944, a new calcium antagonist, assessed in isolated, blood-perfused heart preparations of dogs.
Taira N; Kawada M; Satoh K
J Cardiovasc Pharmacol; 1983; 5(3):349-56. PubMed ID: 6191131
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
Orito K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
[TBL] [Abstract][Full Text] [Related]
8. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
[TBL] [Abstract][Full Text] [Related]
9. Coronary vasodilator compared to cardiac effects of PY 108-068, a new dihydropyridine vasodilator, on isolated, blood-perfused dog-heart preparations.
Wada Y; Satoh K; Taira N
J Cardiovasc Pharmacol; 1984; 6(5):881-7. PubMed ID: 6209495
[TBL] [Abstract][Full Text] [Related]
10. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
Takahashi K; Tsuchida K; Aihara H
Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
[TBL] [Abstract][Full Text] [Related]
11. Coronary vasodilator and cardiac effects of NKY-722, a novel hydrophilic 1,4-dihydropyridine derivative, in the blood-perfused dog heart.
Imagawa J; Satoh K; Taira N
Cardiovasc Drugs Ther; 1989 Mar; 3(1):81-90. PubMed ID: 2487526
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of coronary vasodilator and cardiac effects of nitrendipine by use of isolated, blood-perfused dog heart preparations.
Satoh K; Wada Y; Taira N
Arzneimittelforschung; 1986; 36(1):35-9. PubMed ID: 2937413
[TBL] [Abstract][Full Text] [Related]
13. Cardiac and coronary vasodilator profile of pimobendan, a new cardiotonic drug, revealed by use of isolated, blood-perfused dog heart preparations.
Imagawa J; Satoh K; Taira N
Heart Vessels; 1987; 3(4):182-9. PubMed ID: 3453824
[TBL] [Abstract][Full Text] [Related]
14. Inotropic versus chronotropic, dromotropic, and coronary vasodilator actions of DPI 201-106, a novel positive inotropic agent, in the dog heart.
Takahashi K; Endoh M; Taira N
J Cardiovasc Pharmacol; 1987 Apr; 9(4):451-60. PubMed ID: 2438508
[TBL] [Abstract][Full Text] [Related]
15. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
Yoneyama F; Yamada H; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
18. Is the cardiovascular profile of BRL 34915 characteristic of potassium channel activators?
Gotanda K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1988 Aug; 12(2):239-46. PubMed ID: 2459556
[TBL] [Abstract][Full Text] [Related]
19. Coronary vasodilator versus cardiac effects of MCI-176, a novel quinazolinone calcium antagonist, in the dog heart.
Hosono M; Taira N
J Cardiovasc Pharmacol; 1987 Jun; 9(6):633-40. PubMed ID: 2442528
[TBL] [Abstract][Full Text] [Related]
20. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
Takahashi K; Wada Y; Taira N
Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]